HCV co-infection in HIV positive population in British Columbia, Canada.
about
Internet-based behavioral interventions for preventing HIV infection in men who have sex with men (MSM)Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers.Prevalence and risk factors of Hepatitis C among individuals presenting to HIV testing centers, Hawassa city, Southern Ethiopia.The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities.Preserved MHC-II antigen processing and presentation function in chronic HCV infection.Mortality among British Columbians testing for hepatitis C antibody.Impact of hepatitis C on survival of HIV-infected individuals in Shiraz; South of Iran.HIV/AIDS patients' medical and psychosocial needs in the era of HAART: a cross-sectional study among HIV/AIDS patients receiving HAART in Yunnan, China.CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentCIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.Optimizing hepatitis C therapy in HIV/hepatitis C virus (HCV) coinfected patients: Analysis of HCV viral kinetics on treatment.HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics.Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents.Population-based estimate of hepatitis C virus prevalence in Ontario, Canada.Patient time costs and out-of-pocket costs in hepatitis C.
P2860
Q24234888-6FB9AC01-A7B3-4BD0-A3F7-F2A11B685BF8Q33833241-AEADB54F-8AB3-43CB-AB85-29A5077E33B2Q33933656-F8044E8F-A267-4568-98D3-AA4CC8C26254Q34373050-3B6ABB7E-6069-48D1-8CDA-73645828F0FFQ34423936-401E6AB8-1EAA-4E32-9438-657D634B1408Q34645221-FA9BD8B3-DB96-4F02-B745-CD8C92F3FAC2Q35875249-FB4ACEB0-DC52-47DB-814D-D323BE85BD88Q36652189-FDAD26E7-7224-4653-AEBE-1FC55B43BF84Q37100669-8AF00D65-47FC-4572-8DB0-E154BBC82C9EQ37525649-A399DCE8-8411-42CC-BFCC-E90C114C1EEEQ41787585-296CC7CA-C94C-404B-A153-DBDC8895FE4AQ42196370-CFE906F2-1AA2-4032-B5CA-602E2EF1C2DAQ42259402-5E4EFA1C-E326-4FF9-9FC1-32D42DAB53E1Q47549896-264FDB24-B9E5-492C-8ECE-77804FC03B94Q51175480-5F313CB5-E74A-4F2D-930B-4A72AC5CD2D9
P2860
HCV co-infection in HIV positive population in British Columbia, Canada.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HCV co-infection in HIV positive population in British Columbia, Canada.
@ast
HCV co-infection in HIV positive population in British Columbia, Canada.
@en
type
label
HCV co-infection in HIV positive population in British Columbia, Canada.
@ast
HCV co-infection in HIV positive population in British Columbia, Canada.
@en
prefLabel
HCV co-infection in HIV positive population in British Columbia, Canada.
@ast
HCV co-infection in HIV positive population in British Columbia, Canada.
@en
P2093
P2860
P356
P1433
P1476
HCV co-infection in HIV positive population in British Columbia, Canada.
@en
P2093
Jane A Buxton
John J Spinelli
Margot Kuo
Maria Alvarez
Mark Gilbert
Paul H Kim
P2860
P2888
P356
10.1186/1471-2458-10-225
P407
P50
P577
2010-04-29T00:00:00Z
P5875
P6179
1045640018